See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A majority of Americans are not planning to get a COVID-19 booster ...

Pharmacies across the U.S. have started administering new COVID-19 booster formulations from drugmakers Pfizer and Moderna. The Food and Drug Administration approved the revised mRNA vaccine shots ...

Pfizer's COVID-19 booster shot yields mild to moderate side effects, much like its second dose. Injection-site pain is the most common, as well as headaches and fatigue. See more stories on Insider's ...

A bivalent messenger RNA vaccine targeting both the ancestral and omicron BA.4–BA.5 sublineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pfizer–BioNTech) was introduced in ...

THE PFIZER Covid vaccine is being offered as a booster shot to millions across the UK in a bid to suppress COVID-19 this winter. The pharmaceutical giant signed off its third dose after rigorously ...

On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and ...

The thinking about what risk Covid poses — or doesn't pose — has shifted in recent years. What does it mean for you?

The first new COVID-19 vaccines updated for this fall season should start to be available in mid-September now that both the Food and Drug Administration and the Centers for Disease Control and ...